Article Data

  • Views 2680
  • Dowloads 136

Case Reports

Open Access

Solitary axillary lymph nodal metastasis from primary ovarian cancer: an unusual presentation

  • I. Nazos1
  • M. Tolia2,*,
  • C. Sofoudis3
  • N. Tsoukalas4
  • V. Gougoutsi5
  • G. Vakis6
  • G. Kyrgias2

1Radiation Therapy Unit, 2nd Department of Radiology and University Hospital of Athens "ATTIKON", Haidari, Athens, Greece

2Department of Radiotherapy, University of Thessaly, School of Health Sciences, Faculty of Medicine, Larissa, Greece

3Center for Control Disease and Prevention, Aegean College, Athens, Greece

4Oncology Clinic, 401 General Military Hospital, Athens, Greece

5Blood Transfusion and Hematology Department, "ATTIKON" University Hospital of Athens, Athens, Greece

6Department of Plastic Surgery, National and Kapodistrian University of Athens, School of Health Sciences, Faculty of Medicine, Athens, Greece

DOI: 10.12892/ejgo3725.2017 Vol.38,Issue 5,October 2017 pp.813-814

Published: 10 October 2017

*Corresponding Author(s): M. Tolia E-mail: mariatolia@med.uth.gr

PDF (91.47 kB) View Full-text

Abstract

Background: The most common sites of visceral metastases in ovarian cancer are the liver and lungs, whereas the most frequent sites of lymph nodal involvement are abdominal, para-aortic, mediastinal, and pelvic nodes. Peripheral isolated lymph node metastasis is extremely rare. Case Report: This case represents an ovarian cancer with large metastasis to the right axillary mass. A 79-year-old female presented with a palpable and visibly enlarged mass. A neck lymph nodal mass was found on the CT scan with biopsy showing metastatic carcinoma with morphology and immunophenotype of ovarian primary tumor. Conclusions: Axillary metastasis secondary to ovarian carcinoma is an infrequent clinical entity.

Keywords

Axilla; Lymph node metastasis; Ovarian cancer.

Cite and Share

I. Nazos, M. Tolia, C. Sofoudis, N. Tsoukalas, V. Gougoutsi, G. Vakis, G. Kyrgias. Solitary axillary lymph nodal metastasis from primary ovarian cancer: an unusual presentation. European Journal of Gynaecological Oncology. 2017; 38(5): 813-814. doi: 10.12892/ejgo3725.2017

References

[1] Misailidou V., Malliou P., Beneka A., Karagiannidis A., Godolias G.: “Assessment of patients with neck pain: a review of definitions. selection criteria. and measurement tools”. J. Chiropr. Med., 2010, 9, 49.

[2] Fotiou S., Tserkezoglou A., Zarganis P., Stauropoulou I., Velentzas K., Michalaki V., et al.: “Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence ofepithelial ovarian cancer”. Gynecol. Oncol., 2009, 114, 178.

[3] Takeshima N., Hirai Y., Umayahara K., Fujiwara K., Takizawa K., Hasumi K.: “Lymph node metastasis in ovarian cancer: difference between serous and non serous primarytumors”. Gynecol. Oncol., 2005, 99, 427.

[4] Recine M.A., Deavers M.T., Middleton L.P., Silva E.G., Malpica A.: “Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall”. Am. J. Surg. Pathol., 2004, 28, 1646.

[5] Aydin Ç., Ünalp H.R., Baloğlu A., Inci A.G., Yiğit S., Yavuzcan A.: “Axillary lymph node metastasis from serous ovarian cancer: a case report and review of the literature”. Arch. Gynecol. Obstet., 2009, 279, 203.

[6] Skagias L., Ntinis A., Vasou O., Kondi-Pafiti A., Politi E.: “Ovarian carcinoma presenting with axillary lymph node metastasis: a case diagnosed by fine-needle aspiration and brief review of the literature”. Diagn. Cytopathol., 2008, 36, 891.

[7] Legge F., Petrillo M., Adamo V., Pisconti S., Scambia G., FerrandinaG.: “Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome”. BMC Cancer, 2008, 8, 367.

[8] Ceccarelli F., Barberi S., Pontesilli A., Zancla S., Ranieri E.: “Ovarian carcinoma presenting with axillary lymph node metastasis: a case report”. Eur. J. Gynaecol. Oncol., 2011, 32, 237.

[9] Rizzuto I., Stavraka C., Chatterjee J., Borley J., Hopkins T.G., Gabra H., et al.: “Risk of ovarian cancer relapse score: a prognostic algorithm to predict relapse following treatment for advanced ovarian cancer”. Int. J. Gynecol. Cancer, 2015, 25, 416.

Submission Turnaround Time

Top